Merck & Co News

Unusual Options Activity: PDD, MRK and Others Attract Market Bets, PDD V/OI Ratio Reaches 175.2

EST May 3rd Closing Delivery - In the last three hours of trading, 6 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

moomoo News16:30 ET

Express News | Merck & Co Anticipates Actions Under 2024 Restructuring Program Will Result In Cumulative Annual Net Cost Savings Of About $750M By End Of 2031; Expects To Record Charges Of About $800M In 2024 Related To 2024 Restructuring Program

Benzinga16:20 ET

Express News | Merck & Co Inc: Expects to Record Charges of About $800 Mln in 2024 Related to 2024 Restructuring Program

Reuters16:16 ET

Express News | Merck & Co: Anticipates Actions Under 2024 Restructuring Program Will Result in Cumulative Annual Net Cost Savings of About $750 Mln by End of 2031

Reuters16:15 ET

Express News | NYSE Order Imbalance 100905.0 Shares on Buy Side

Reuters15:50 ET

Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy

ImmunityBio Inc (NASDAQ:IBRX) shares are trading down after an early morning high on Friday after the company announced an exclusive global arrangement with the Serum Institute of India, the world's l

Benzinga12:19 ET

Janux Therapeutics Gains Amid Renewed Takeover Speculation

Seeking AlphaMay 2 16:09 ET

Express News | NYSE Order Imbalance 431988.0 Shares on Sell Side

ReutersMay 2 15:50 ET

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaMay 2 13:35 ET

Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration

After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co Inc (NYSE:MRK) just reported encouraging data from its Phase III gastric cancer treatment trial after

BenzingaMay 2 12:53 ET

Cerevance Receives Milestone Payment Under Alzheimer's Collaboration With Merck

Seeking AlphaMay 2 12:40 ET

Express News | Merck & Co Inc : Jefferies Raises Target Price to $150 From $145

ReutersMay 2 02:08 ET

15 Best Places to Retire in Florida That You've Never Heard Of

Yahoo FinanceMay 1 18:52 ET

Express News | NYSE Order Imbalance 85022.0 Shares on Buy Side

ReutersMay 1 15:50 ET

Redburn Atlantic Adjusts Price Target on Merck to $148 From $142

Merck & Company (MRK) has an average outperform rating and a price target range of $118 to $155, according to analysts polled by Capital IQ. Price: 130.91, Change: +1.69, Percent Change: +1.31

MT NewswiresMay 1 08:21 ET

Express News | Merck's Phase 3 KEYNOTE-811 Trial Of Keytruda Met Dual Primary Endpoint of Overall Survival as First-Line Treatment Of HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

BenzingaMay 1 07:17 ET

Express News | Merck & Co Inc - Safety Profile of Keytruda in Trial Consistent With That Observed in Previously Reported Studies, No New Safety Signals Identified

ReutersMay 1 07:16 ET

Express News | Merck Announces Phase 3 Keynote-811 Trial Met Dual Primary Endpoint of Overall Survival (Os) as First-Line Treatment in Patients With Her2-Positive Advanced Gastric or Gastroesophageal Junction (Gej) Adenocarcinoma

ReutersMay 1 07:15 ET

Is Merck (NYSE:MRK) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe

Simply Wall StApr 30 07:02 ET

Express News | NYSE Order Imbalance 151490.0 Shares on Sell Side

ReutersApr 29 15:50 ET